TNF-α up-regulates renal MIF expression in rat crescentic glomerulonephritis

Molecular Medicine

Volumn 3, Issue 2, 1997, Pages 136-144

  Lan, Hui Y ^a   Yang, Niansheng ^a   Metz, Christine ^b   Mu, Wei ^a   Song, Qing ^a   Nikolic Paterson, David J ^a   Bacher, Michael ^b   Bucala, Richard ^b   Atkins, Robert C ^a  

^a MONASH MEDICAL CENTRE   (Australia)

^b PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; PROTEIN; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR BINDING PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULONEPHRITIS; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY; KIDNEY FUNCTION; MACROPHAGE; MALE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; RECEPTOR UPREGULATION;

EID: 0030967360     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401805     Document Type: Article

References (25)

1. David JR. (1966) Delayed hypersensitivity in vitro: Its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl. Acad. Sci. U.S.A. 56: 72-77.
2. Bloom BR, Bennett B. (1966) Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153: 80-82.
3. Nishno T, Bernhagen J, Shijki H, Calandra T, Dohl K, Bucala R. (1995) Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland. Mol. Med. 1: 781-788.
4. Calandra T, Bernhagen J, Mitchell RA, Bucala R. (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179: 1895-1902.
5. Lan HY, Mu W, Yang N, et al. (1996) De novo renal expression of macrophage migration inhibitory factor (MIF) during the development of rat crescentic glomerulonephritis. Am. J. Pathol. 149: 1119-1127.
6. Bernhagen J, Calandra T, Mitchell RA, et al. (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365: 756-759.
7. Calandra T, Bernhagen J, Metz CN, et al. (1995) MIF as a glucocorticoid-induced modulator of cytokine production. Nature 376: 68-71.
8. Bacher M, Metz CN, Calandra T, et al. (1996) An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc. Natl. Acad. Sci. U.S.A. 93: 7849-7854.
9. Pozzi LA, Weiser WY. (1992) Human recombinant migration inhibitory factor activates human macrophages to kill tumor cells. Cell Immunol. 145: 372-379.
10. Hruby ZW, Shirota K, Jothy S, Lowry RP. (1991) Antiserum against tumor necrosis factor-alpha and a protease inhibitor reduce immune glomerular injury. Kidney Int. 40: 43-51.
11. Baud L, Fouqueray B, Philipp C. (1994) Involvement of tumor necrosis factor-alpha in glomerular injury. Springer Semin. Immunopathol. 16: 53-61.
12. Lan HY, Paterson DJ, Atkins RC. (1991) Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis. Kidney Int. 40: 425-433.
13. Lan HY, Nikolic-Paterson DJ, Mu W, Vannice JL, Atkins RC. (1995) Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat. Kidney Int. 47: 1303-1309.
14. Lan HY, Mu W, Nikolic-Paterson DJ, Atkins RC. (1995) A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: Use of microwave oven heating to block antibody crossreactivity and retrieve antigens. J. Histochem. Cytochem. 43: 97-102.
15. Dijkstra CD, Dopp EA, Joling P, Kraal G. (1985) The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 54: 589-599.
16. Bacher M, Meinhardt A, Lan HY, et al. (1997) MIF expression in experimentally-induced endotoxemia. Am. J. Pathol. 150: 235-246.
17. Mitchell R, Bacher M, Bernhagen J, Pushkarskaya T, Seldin MF, Bucala R. (1995) Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MTF). J. Immunol. 154: 3863-3870.
18. Sakai M, Nishihira J, Hibiya Y, Koyama Y, Nishi S. (1994) Glutathione binding rat liver 13k protein is the homologue of the macrophage migration inhibitory factor. Biochem. Mol. Biol. Int. 33: 439-446.
19. Lan HY, Mn W, Ng Y-Y, Nikolic-Paterson DJ, Atkins RC. (1996) A simple, reliable, and sensitive method of nonradioactive in situ hybridization: Use of microwave heating to improve hybridization efficiency and preserve tissue morphology. J. Histochem. Cytochem. 44: 281-287.
20. Lan HY, Bacher M, Mu W, et al. (1996) Blockade of macrophage migration inhibitory factor (MIF) inhibits rat crescentic glomerulonephritis (GN). (abstract) J. Am. Soc. Nephrol. 7: 1707.
21. Nishikawa K, Guo YJ, Miyasaka M, et al. (1993) Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis. J. Exp. Med. 177: 667-677.
22. Tang WW, Qi M, Warren JS. (1996) Monocyte chemoattractant protein 1 mediates glomerular macrophage infiltration in anti-GBM Ab GN. Kidney Int. 50: 665-671.
23. Beg AA, Finco TS, Nantermet PV, Baldwin AS Jr. (1993) Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol. Cell Biol. 13: 3301-3310.
24. Trede NS, Tsytsykova AV, Chatila T, Goldfeld AE, Geha RS. (1995) Transcriptional activation of the human TNF-alpha promoter by superantigen in human monocytic cells: Role of NF-kappa B. J. Immunol. 155: 902-908.
25. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. (1995) Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270: 286-290.